HOME >> MEDICINE >> NEWS
First Quantum Grant to fund stem cell repair of damage from stroke

HOUSTON, Oct. 9, 2006 The National Institutes of Health has named researchers at Baylor College of Medicine (BCM) and Rice University in Houston as the first and only recipients of the inaugural Quantum Grant for their international research initiative to regenerate damaged brain cells and blood vessels for the treatment of stroke.

The three-year, $2.9 million grant, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the NIH, will support research on neuro-vascular regeneration, which will make new brain tissues in the laboratory. The new brain tissue is planned to have its own blood supply to allow it to be placed into the damaged brains of stroke patients where it will provide a source of neural and vascular cells that will continue to develop and differentiate, repairing the injured tissue in the process.

"This project represents an integrated effort among leading scientists who have jointly authored numerous publications, mentored students and postdoctoral fellows, as well as collaborated on Bioengineering Research Partnership grants," said Jennifer West, who is leading the project's efforts at Rice. West is the Isabel C. Cameron Professor of Bioengineering and director of Rice's Institute of Biosciences and Bioengineering.

The newly created NIBIB Quantum Grants Program supports researchers in the development of innovative biomedical technologies in hopes of making a significant impact in the prevention, diagnosis and treatment of disease. Funding was awarded to only one grant application out of more than 100 submitted.

Karen Hirschi, deputy director of the Stem Cell and Regenerative Medicine Center within the Center for Cell and Gene Therapy at BCM, is the principal investigator for the "Neuro-Vascular Regeneration" project, which will be conducted in conjunction with an interdisciplinary team of researchers at Rice, the National Institute for Medical Research in London, and Kin
'"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
9-Oct-2006


Page: 1 2

Related medicine news :

1. First of its kind report on how children with brain tumors perform at school
2. First clinical trial of gene therapy for childhood blindness
3. First nationwide child health and air pollution study commences
4. First step in developing heart hormone-based pill to control high blood pressure
5. First greenhouse gas animations produced using Envisat SCIAMACHY data
6. First ozone and nitrogen dioxide measurements from MetOp-A
7. First-degree fetal heart block may be reversible
8. 10 outstanding scientists chosen as First Environmental Health Science Fellows
9. First-time mothers at increased risk for postpartum mental disorders
10. Transforming knowledge into economic benefits -- EPSRCs First Knowledge Transfer Challenge Awards
11. First major study of mammalian disorderly proteins

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: First Quantum Grant fund stem cell repair damage from stroke

(Date:5/6/2015)... Boise, Idaho (PRWEB) May 06, 2015 More ... diet that was created by Brian Flatt, personal trainer and ... between 12 and 23 pounds in just three weeks or ... diet has been scientifically tested and found to work ... or body type. On average, people lose between 12 and ...
(Date:5/5/2015)... It’s not your usual Veterans Affairs outreach event. , ... to the 3rd Annual “Crusin Lincoln” Show & Shine event ... VA Clinic, 600 S. 70th St. , The event is ... rides, but also to talk to employees of the Department ... from the VA Nebraska-Western Iowa Health Care System, Vet Centers, ...
(Date:5/5/2015)... The Florida Comprehensive Epilepsy and Seizure Disorders Center ... the National Association of Epilepsy Centers (NAEC) as ... a specialized epilepsy center is to provide an ... seizure syndrome, comprehensive epilepsy education for patients and ... diagnosis and surgical treatment or access to it ...
(Date:5/5/2015)... NC (PRWEB) May 05, 2015 Carlini ... Indian Trail, Monroe, Matthews, Charlotte and surrounding areas. The ... field of accounting. This company provides assistance in making ... as they prepare individual or corporate tax returns for ... in the cloud that allows clients (and Carlini CPA) ...
(Date:5/5/2015)... 05, 2015 Horizon Blue Cross Blue ... and secure credit rating of “A” from Standard & ... last week, the Wall Street ratings agency cited the ... position” in determining the rating and “stable” outlook. , ... of our top priorities, so we are pleased to ...
Breaking Medicine News(10 mins):Health News:Brian Flatt Announces The 3 Week Diet - A Scientifically Proven Diet Plan 2Health News:Florida Hospital Tampa Epilepsy Program Earns Designation as a Level 4 Epilepsy Center by the National Association of Epilepsy Centers (NAEC) 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2
(Date:5/5/2015)... , May 5, 2015 Ardelyx, Inc. ... focused on cardio-renal, gastrointestinal, and metabolic diseases, today ... evaluating tenapanor in Stage 3 chronic kidney disease ... did not meet the primary endpoint of decreasing ... to patients receiving placebo. Ardelyx ...
(Date:5/5/2015)... WORTH, Texas , May 5, 2015 ... was valued at $94.9 million in 2014, and is ... a CAGR of 7.8% from 2014 to 2019. ... Glaucoma Surgery Device Market for an analysis of industry ... and figures. http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html ...
(Date:5/5/2015)...  Desert Valley Medical Center, named a Top 100 Hospitals® ... U.S. hospital to deploy the wireless Leaf Patient Monitoring System ... duration of labor and risk of caesarian births. ... caesarean birth is reduced in mothers who are upright and ... are given epidurals and tend to lie in their labor ...
Breaking Medicine Technology:Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 2Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 3Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 4Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 5Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus and Albuminuria 6North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4
Cached News: